US Stock MarketDetailed Quotes

NVS Novartis AG

Watchlist
  • 97.640
  • +0.500+0.51%
Close Jan 3 16:00 ET
  • 97.500
  • -0.140-0.14%
Post 16:14 ET
195.21BMarket Cap11.46P/E (TTM)

About Novartis AG Company

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Company Profile

SymbolNVS
Company NameNovartis AG
Listing DateMay 11, 2000
Founded1996
CEOMr. Vasant Narasimhan
MarketNYSE
Employees76057
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressLichtstrasse 35
CityBasel
ProvinceBasel-Stadt (Basle Town)
CountrySwitzerland
Zip Code4056
Phone41-61-324-11-11

Company Executives

  • Name
  • Position
  • Salary
  • Vasant Narasimhan
  • Chief Executive Officer
  • 13.27M
  • Klaus Moosmayer
  • Chief Ethics, Risk and Compliance Officer
  • --
  • Harry Kirsch
  • Chief Financial Officer
  • 6.53M
  • Karen L. Hale
  • Chief Legal Officer
  • --
  • Robert Kowalski
  • Chief People and Organization Officer
  • --
  • Aharon Gal, PhD
  • Chief Strategy and Growth Officer
  • --
  • Dr. Shreeram Aradhye, M.D.
  • President, Development and Chief Medical Officer
  • --
  • Victor Bulto
  • President, US
  • 5.16M
  • Fiona Marshall, PhD
  • President, Biomedical Research
  • --
  • Simon Moroney, D.Phil.
  • Vice Chairman of the Board
  • 460.00K
  • Patrick Horber
  • President, International
  • 6.68M
  • Dr. Steffen Lang, PhD
  • President, Operations
  • --
  • Joerg Reinhardt, PhD
  • Chairman of the Board
  • 3.80M
  • Elizabeth Doherty
  • Independent Director
  • 450.00K
  • Ana de Pro Gonzalo
  • Independent Director
  • 390.00K
  • Ton Buechner
  • Independent Director
  • 424.68K
  • Daniel Hochstrasser
  • Independent Director
  • 376.34K
  • Patrice Bula
  • Lead Independent Director
  • 413.78K
  • Dr. Charles L. Sawyers
  • Independent Director
  • 360.00K
  • Frans Van Houten
  • Independent Director
  • 394.68K
  • William Thomas Winters
  • Independent Director
  • 360.00K
  • John Douglas Young
  • Independent Director
  • 304.68K
  • Dr. Nancy C. Andrews, M.D.,PhD
  • Independent Director
  • 360.00K
  • Bridgette P. Heller
  • Independent Director
  • 430.00K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.